Citation: Khalid Eltahir Khalid. Vitamin D receptor gene polymorphisms in Sudanese children with type 1 diabetes[J]. AIMS Genetics, 2016, 3(3): 167-176. doi: 10.3934/genet.2016.3.167
[1] | Ke-Sheng Wang, Xuefeng Liu, Daniel Owusu, Yue Pan, Changchun Xie . Polymorphisms in the ANKS1B gene are associated with cancer, obesity and type 2 diabetes. AIMS Genetics, 2015, 2(3): 192-203. doi: 10.3934/genet.2015.3.192 |
[2] | Harem Othman Smail . The roles of genes in the bitter taste. AIMS Genetics, 2019, 6(4): 88-97. doi: 10.3934/genet.2019.4.88 |
[3] | Harem Othman Smail . The epigenetics of diabetes, obesity, overweight and cardiovascular disease. AIMS Genetics, 2019, 6(3): 36-45. doi: 10.3934/genet.2019.3.36 |
[4] | Alena V Malakhova, Olga I Rudko, Vladimir V Sobolev, Artemii V Tretiakov, Elena A Naumova, Zarema G Kokaeva, Julia E Azimova, Eugene A Klimov . PDE4B gene polymorphism in Russian patients with panic disorder. AIMS Genetics, 2019, 6(3): 55-63. doi: 10.3934/genet.2019.3.55 |
[5] | Tahereh Karamzadeh, Hamzeh Alipour, Marziae Shahriari-Namadi, Abbasali Raz, Kourosh Azizi, Masoumeh Bagheri, Mohammad D. Moemenbellah-Fard . Molecular characterization of the netrin-1 UNC-5 receptor in Lucilia sericata larvae. AIMS Genetics, 2019, 6(3): 46-54. doi: 10.3934/genet.2019.3.46 |
[6] | Mohammad Hashemi, Fatemeh Bizhani, Hiva Danesh, Behzad Narouie, Mehdi Sotoudeh, Mohammad Hadi Radfar, Mehdi Honarkar Ramezani, Gholamreza Bahari, Mohsen Taheri, Saeid Ghavami . MiR-608 rs4919510 C>G polymorphism increased the risk of bladder cancer in an Iranian population. AIMS Genetics, 2016, 3(4): 212-218. doi: 10.3934/genet.2016.4.212 |
[7] | Seoyoung Yoon, Yong-Ku Kim . The role of immunity and neuroinflammation in genetic predisposition and pathogenesis of Alzheimer's disease. AIMS Genetics, 2015, 2(3): 230-249. doi: 10.3934/genet.2015.3.230 |
[8] | Noel Pabalan, Neetu Singh, Eloisa Singian, Caio Parente Barbosa, Bianca Bianco, Hamdi Jarjanazi . Associations of CYP1A1 gene polymorphisms and risk of breast cancer in Indian women: a meta-analysis. AIMS Genetics, 2015, 2(4): 250-262. doi: 10.3934/genet.2015.4.250 |
[9] | Natalie J. Nokoff, Sharon Travers, Naomi Meeks . Two cases of androgen insensitivity due to somatic mosaicism. AIMS Genetics, 2015, 2(2): 104-109. doi: 10.3934/genet.2015.2.104 |
[10] | Jarrett Barnhill, James Bedford, James Crowley, Takahiro Soda . A search for the common ground between Tic; Obsessive-compulsive and Autism Spectrum Disorders: part I, Tic disorders. AIMS Genetics, 2017, 4(1): 32-46. doi: 10.3934/genet.2017.1.32 |
Type 1 diabetes mellitus (T1DM) is a multi-factorial autoimmune disorder, characterized by the destruction of pancreatic beta cells resulting in the deficiency of insulin secretion [1], caused by complex interaction between genetic and environmental factors, accounting for 5-10% of diabetes cases worldwide [2], and it is common among children and young adults and usually developed early under age 30 years.
It is known that the active vitamin D (1, 25-dihydroy vitamin D3), play an important role in the regulation of immune cells proliferation and differentiations, lymphocytes activation, cytokines production [3], and insulin secretion [4]. Vitamin D bioactivity is through the vitamin D receptor (VDR), which is belonging to the nuclear hormone receptors superfamily[5].
The VDR gene is located on the long arm of chromosome 12 (12q12) and 14 (q14), and four common single nucleotide polymorphisms (SNPs) have been identified [6,7,8,9] namely Bsm1, Fok1, Apa1 and Taq1polymorphisms (designated as rs1544410, rs10735810, rs7975232, and rs731236 SNP, respectively). VDR polymorphism was found to be associated with many autoimmune disorders in human, such as celiac disease [10], multiple sclerosis [11,12], systemic lupus erythematosus [13,14,15], rheumatoid arthritis [16,17], and hashimoto, s throiditis [18]. The role of VDR polymorphisms in the pathogenesis of T1DM was not clear, large number of studies [5,7,19,20,21,22,23,24,25] has been investigated the association between the aforementioned SNPs and the risk of T1DM but the results were inconsistent.
This study was conducted to investigate the association between VDR polymorphisms (at position Bsm1, Taq1 and Apa1) and susceptibility to T1DM in Sudanese population.
The study encompasses 174 T1DM patients [mean onset age 7.68±3.59 (range, 1-16) years old; 90 female and 84 male] refer to the diabetic clinic at Wad Medani Pediatric hospital which was founded in 1987 to serve children at Gezira state and the out skirt provinces. The patients group was diagnosed according the American DiabetesAssociation for type 1 diabetes [2]. Fifty six unrelated healthy children [9.50±4.23 (range 4-16) years old; 32 female and 24 male]. The patients were classified into metabolically poor glycemic control with HbA1c > 8% and well glycemic control with HbA1c≤8%. HbA1c was assessed by chromatographic-spectrophotometer ion exchange (BioSystems). The demographic and the clinical information were obtained from each subject through well structured questionnaire. Informed consent was obtained from the children guardians or relatives, and the Faculty of Medicine Institutional committee approval was obtained.
DNA was extracted from the whole blood by using the QIAamp DNA Blood Mini Kit protocol (Qiagen, USA). The target gene of the VDR was extracted from whole gene sequence available at the Pubmed (NCBI Reference Sequence: NG_008731.1), and amplified by the PCR based on primers specific for Bsm1, Apa1 and Taq1polymorphisms (designated as rs1544410, rs7975232, and rs731236 SNP, respectively) (Table 1). The PCR condition and digestion used for amplification of Bsm1 as follows; 94 °C for 5 min, and 30 cycles using the following temperature profile: 94 °C for 1 min, 56 °C for 1 min, 72 °C for 1 min, and final elongation for 5 min. The PCR products were 825-bp long (B allele), and were digested with Mva12691 (BsmI) at 37 °C for 3 hrs, and then subjected to electrophoresis in 2% agarose gel stained with 5 μL ethidium bromide. The lengths of the restriction fragments were 649 and 176 bp (mutant b allele). The PCR condition and digestion used for amplification of Apa1 and Taq1 as follows; 94 °C for 10 min, and 30 cycles using the following temperature profile: 94 °C for 1 min, 62 °C for 1 min, 72 °C for 1 min, and final elongation for 5 min. The PCR products were 716-bp long (A or T alleles) and were digested with ApaI and TaqI at 37 °C and 65 °C for 2 hrs respectively, and then subjected to electrophoresis in 2% agarose gel stained with 5 μL ethidium bromide. The lengths of the ApaIrestriction fragments were 481 and 235 bp (mutant “a” allele), and for TaqI were 419 and 297 bp. Five percent of the samples were checked twice for results accuracy.
SNP | PCR primer sequences (5’-3’) | Fragment size | |
Bsm1 | Forward | CAA CCA AGA CTA CAA GTA CCG CGT CAG TGA | B: 825 bp |
Reverse | AAC CAG CGG AAG AGG TCA AGG G | b: 649 bp, 176 bp | |
Apa1 | Forward | GGG ACG CTG AGG GAT GGC AGA GC | 716 bp |
Reverse | GGA AAG GGG TTA GGT TGG ACA GGA | 481 bp, 235 bp | |
Taq1 | Forward | GGG ACG CTG AGG GAT GGC AGA GC | 716 |
Reverse | GGA AAG GGG TTA GGT TGG ACA GGA | 481 bp, 235 bp |
A chi-squared test (χ2 test) was used to evaluate the associations between different genotypes of Bsm1, Taq1, and Apa1 variants and the disease (T1DM vs controls). The comparisons of the genotype frequencies between groups was analysed using the t-test. Odd ratios (ORs) and 95% confidence intervals (CIs) were calculated for each allele and genotype using logistic regression. The differences were considered significant if the P-value less than 0.05.
The base line characteristics of the study subjects are shown in (Table 2). The male to female ratio in diabetic and control groups was 1:1.1 and 4.3 respectively. Among diabetic patients 59.2% were having family history of diabetes, the mean HbA1c among diabetic group was significantly high (P < 0.001) as compared with the control group, on the contrary, BMI which was significantly low among diabetic group, 85.6% of T1DM patients characterized by metabolically poor diabetic control.
Characteristics | Diabetics (N = 174) | Non diabetics (N = 56) | |
Gender (years) | Male | 84 | 24 |
Female | 90 | 32 | |
Age at diagnosis (years) | 11.48 ± 3.39 | 9.50 ± 4.23 | |
Age at onset of disease | 7.68 ± 3.59 | - | |
Duration of diabetes (years) | 3.82 ± 2.82 | - | |
Family history of diabetes | Negative | 71 | 40 |
Positive | 103 | 16 | |
BMI (kg/m2) | 16.22 ± 2.37 | 19.10 ± 4.61* | |
HbA1c (%) (normal rang = 5.4–14.5) | 10.72 ± 2.18 | 6.05 ± 1.34* | |
Diabetic control | Well (≤8.0%) | 25 (14.4%) | - |
Poor (>8.0%) | 149 (85.6%) | - | |
* p < 0.001 |
There was a difference in the VDR genotype and allele frequencies between T1DM patients and the control group. Bsm1 BB and B allele were significantly (P=0.004 and p=0.001 respectively) higher frequency in patients with T1DM (Table 3). The complete cleavage of Bsm1 to the target gene into homozygous (wild type BB=825 bp or mutant bb=649 bp) (Figure 1). On the other hand, Taq1 TT genotype (p=0.012) and T allele (p=0.05) were more frequent among study patients (Table 4), where as its complete cleavage of the target gene into homozygous (wild type TT=712 bp or mutant tt=419 bp) (Figure 2). Apa1 AA genotype (p=0.932) and A allele (p=0.862) were less frequent in TIDM patients without significant difference (Table 5), its complete cleavage to the target gene generates homozygous (wild type AA=716 bp or mutant aa=481 bp) (Figure 3). Bms1 BB genotype frequency was significantly (p < 0.02) high among patients with poor metabolic control group of T1DM as compared with well metabolic control group (Table 6).
Bsm1 | Genotypes | Allele | |||
Group | Bb | BB | Bb | B | B |
Diabetic patients | 17 (17%) | 51 (51%) | 32 (32%) | 0.61 | 0.58 |
Control | 21 (42%) | 19 (38%) | 10 (20%) | 0.42 | 0.39 |
P-value | = 0.004a | = 0.001 | |||
χ2 = 11.145 | χ2 = 11.014 | ||||
a statistical analysis was performed between BB + Bb and bb; Odd Ratio=0.283; 95% CI 0.131-0.609. |
Tag1 | Genotypes | Allele | |||
Group | Tt | TT | Tt | T | T |
Diabetic patients | 22 (22%) | 63 (63%) | 15 (15%) | 0.54 | 0.46 |
Control | 16 (32%) | 19 (38%) | 15 (30%) | 0.41 | 0.49 |
P-value | = 0.012a | = 0.05 | |||
χ2 = 8.877 | χ2 = 4.688 | ||||
a statistical analysis was performed between TT + Tt and tt; Odd Ratio=2.429; 95% CI 1.073-5.496. |
Apa1 | Genotypes | Allele | |||
Group | Aa | AA | Aa | A | A |
Diabetic patients | 44 (44%) | 49 (49%) | 7 (7%) | 0.68 | 0.32 |
Control | 21 (42%) | 26 (52%) | 3 (6%) | 0.68 | 0.32 |
P-value | = 0.932 a | = 0.862 | |||
χ2 = 0.141 | χ2 = 0.054 | ||||
a statistical analysis was performed between AA + Aa and aa; Odd Ratio=1.085; 95% CI 0.546-2.156. |
Genotype frequency | HbA1c (>8%) (n = 87) | HbA1c (≤8%) group (n = 13) | P value | |
Bsm1 | BB | 55 (63.2 %) | 6 (46.2 %) | 0.02a |
Bb | 9 (12.3 %) | 3 (23.0 %) | ||
Bb | 23 (26.4 %) | 4 (30.8 %) | ||
Taq1 | TT | 45 (41.4 %) | 7 (53.8%) | 0.13b |
Tt | 29 (33.3 %) | 4 (30.8 %) | ||
Tt | 13 (14.9 %) | 2 (15.4 %) | ||
Apa1 | AA | 47 (54.0 %) | 7 (53.8 %) | 0.46c |
Aa | 33 (37.9 %) | 5 (38.5 %) | ||
Aa | 7 (8.0 %) | 1 (7.7 %) | ||
a, b, c statistical analysis was performed between BB + Bb and bb; TT + Tt and tt; AA + Aa and aa. |
Vitamin D could play a role in the pathogenesis of autoimmune diseases particularly T1DM, with its metabolites could inhibit T cell proliferation and suppress the production of certain pro-inflammatory cytokine such as TNF-α and IL-1 [26,27,28,29]. Our study showed high frequency of patients with family history of diabetes. An early family study has supported the association between first degree relatives with T1DM and the risk of developing T1DM [30], while other study indicated that, this association depends on which parent has diabetes [31]. Several studies investigated the association between VDR gene polymorphisms and T1DM in different populations like Greece [5], Taiwanese [7], Germany [19], Finnish [20], Portuguese [21], Japanese [22], Iranian [23], Dalmatian[24], and Egyptians [25]. Most of the aforementioned studies reported controversial findings, which were most likely due to ethnic variations in addition to the role of the environmental and genetic factors. Thus far, no study indicated the association between VDR gene polymorphisms and susceptibility to T1DM in Sudanese population. Sudanese regions, particularly central Sudan, is inhabited by ethnically, linguistically and culturally diverse populations which makes the comparison of our results with previous studies from different regions is comparably useful, previous studies combines the genotype data of Sudanese populations with other subordinate countries such as Somalia, Egypt and Uganda [32], in addition to Ethiopia and Fulani [33]. Our study analysed three well characterized VDR polymorphisms (Bsm1, Taq1, and Apa1) among Sudanese T1DM children. We were not being able to investigate the fourth Fok1 polymorphism owing to difficulties associated with the enzyme itself.
Bsm1 and Apa1 are located in the intron between exon 8-9, which seems not affecting VDR protein structure, however, Bsm1 may influence VDR mRNA stability because it was found strongly linked with the 3 polyA microsatellite repeat in 3’untranslated region [3,38]. Our results showed both Bsm1 BB genotype and B allele were significantly high in patients than controls and is associated with increased risk of T1DM. This result was consistent with findings from other populations [13,16,35,36]. On the contrary, population study in Iran [14], showed no significant association between Bsm1 and susceptibility to T1DM, and was found to have protective role in Greece population [5].
Taq1 is a silent SNP within the 3’-noncoding sequences in exon 9 [37], its exact role in the pathogenesis of T1DM is not well defined. In this study and similar to Bsm1, Taq1 TT genotype and T allele exerted susceptibility action to T1DM, which is agreed with other study populations from Greece and Uruguayan [5,29]. This data was not in agreement with other populations such as Portuguese, Iranian, and Korean, where there was no association found [21,23,39], or there was low frequency in Egyptian population [25]. Our data showed no significant difference in Apa1 between patients and control. In agree with our result, Apa1 genotype and alleles frequencies showed no significant differences between T1DM and the control among Portuguese [21]. In contrary, Apa1 gene polymorphism was found associated with T1DM in Greece and Taiwanese populations [5,7].
In conclusion, the VDR Bsm1 and Taq1 were associated with susceptibility to T1DM among Sudanese population. Our sample size was not large enough to represent the whole population, although it enrols the majority of the patients from central Sudan, nevertheless, the strength of an association between SNPS and T1DM in this study is measured by the odds ratio (OR). Hardy-Weinberg equilibrium for the genotypes was not used in this study because of small sample size and to override violation. Since Sudan is known as small continent and characterized by different ethnic groups, further studies from different regions is necessary to correlate between the genetic and environmental factors, VDR polymorphisms, and T1DM.
Thanks to Dr. Mohammed Osman Abdelwahid, Department of Molecular Biology, National Cancer Institute, University of Gezira for his contribution.
The author declares no conflict of interest.
[1] | Barrett JC, Clayton DG, Concannon P, et al. (2009) Genome-wide association study and meta-analysis ?nd that over 40 loci affect risk of type 1 diabetes. Nat Genet 41: 703-707. |
[2] | American Diabetes Association (2005) Diagnosis and classi?cation of diabetes mellitus. Diabetes Care 28: S37-S42. |
[3] | Uitterlinden AG, Fang Y, Van Meurs JB, et al. (2004) Genetics and biology of vitamin D receptor polymorphisms. Gene 33: 8143-8156. |
[4] |
Wang Q, Xi B, Reilly KH, et al. (2012) Quantitative assessment of the associations between four polymorphisms (FokI, ApaI, BsmI, TaqI) of vitamin D receptor gene and risk of diabetes mellitus. Mol Biol Rep 39: 9405-9414. doi: 10.1007/s11033-012-1805-7
![]() |
[5] |
Panierakis C, Goulielmos G, Mamoulakis D, et al. (2009) Vitamin D receptor gene polymorphisms and susceptibility to type 1 diabetes in Crete Greece. Clin Immunol 133: 276-281. doi: 10.1016/j.clim.2009.08.004
![]() |
[6] | Capoluongo E, Pitocco D, Concolino P, et al. (2006) Slight association between type 1 diabetes and ‘‘ff’’ VDR FokI genotype in patients from the Italian Lazio Region. Lack of association with diabetes complications. Clin Biochem 39: 888-892. |
[7] | Chang TJ, Lei HH, Yeh JI, et al. (2000) Vitamin D receptor gene polymorphism in?uences susceptibility to type 1 diabetes mellitus in the Taiwanese population. Clin Endocrinol 52: 575-580. |
[8] | Audí L, Martí G, Esteban C, et al. (2004) VDR gene polymorphism at exon 2 start codon (FokI) may have in?uenced type 1 diabetes mellitus susceptibility in two Spanish populations. Diabetic Med 21: 393-394. |
[9] | Miyamoto K, Kesterson RA, Yamamoto H, et al. (1997) Structural organization of the human vitamin D receptor chromosomal gene and its promoter. Mol Endocrinol 11: 1165-1179. |
[10] |
San-Pedro JI, Bilbao JR, Perez de Nanclares G, et al. (2005) Heterogeneity of vitamin D receptor gene association with celiac disease and type 1 diabetes mellitus. Autoimmunity 38: 439-444. doi: 10.1080/08916930500288455
![]() |
[11] | Narooie-Nejad M, Moossavi M, Torkamanzehi A, et al. (2015) Vitamin D Receptor Gene Polymorphism and the Risk of Multiple Sclerosis in South Eastern of Iran. J Mol Neurosci 56: 572-576. |
[12] | Tizaoui K, Kaabachi W, Hamzaoui A, et al. (2015) Association between vitamin D receptor polymorphisms and multiple sclerosis: systematic review and meta-analysis of case-control studies. Cell Mol Immunol 12: 243-252. |
[13] | Jacobs J, Voskuyl AE, Korswagen LA, et al. (2015) The association between FOK-I vitamin D receptor gene polymorphisms and bone mineral density in patients with systemic lupus erythematosus. Clin Exp Rheumatol 33: 765. |
[14] |
Carvalho C, Marinho A, Leal B, et al. (2015) Association between vitamin D receptor (VDR) gene polymorphisms and systemic lupus erythematosus in Portuguese patients. Lupus 24: 846-853. doi: 10.1177/0961203314566636
![]() |
[15] | Xiong J, He Z, Zeng X, et al. (2014) Association of vitamin D receptor gene polymorphisms with systemic lupus erythematosus: a meta-analysis. Clin Exp Rheumatol 32:174-181. |
[16] |
Song GG, Bae SC, Lee YH (2016) VitaminD receptor FokI, BsmI, and TaqI polymorphisms and susceptibility to rheumatoid arthritis : A meta-analysis. Z Rheumatol 75: 322-329. doi: 10.1007/s00393-015-1581-6
![]() |
[17] | Tizaoui K, Hamzaoui K (2014) Association between VDR polymorphisms and rheumatoid arthritis disease: Systematic review and updated meta-analysis of case-control studies. Immunobiology 220: 807-816. |
[18] |
Djurovic J, Stojkovic O, Ozdemir O, et al. (2015) Association between FokI, ApaI and TaqI RFLP polymorphisms in VDR gene and Hashimoto’s thyroiditis: preliminary data from female patients in Serbia. Int J Immunogenet 42: 190-194. doi: 10.1111/iji.12199
![]() |
[19] |
Ramos-Lopez E, Brück P, Jansen T, et al. (2007) CYP2R1 (vitamin D 25-hydroxylase) gene is associated with susceptibility to type 1 diabetes and vitamin D levels in German. Diabetes Metab Res Rev 23: 631-636. doi: 10.1002/dmrr.719
![]() |
[20] | Turpeinen H, Hermann R, Vaara S, et al. (2003) Vitamin D receptor polymorphisms: no association with type 1 diabetes in the Finnish population. Eur J Endocrinol 149: 591-596. |
[21] | Lemos MC, Fagulha A, Coutinho E, et al. (2008) Lack of association of vitamin D receptor gene polymorphisms with susceptibility to type 1 diabetes mellitus in the Portuguese population. Hum Immunol 69: 134-138. |
[22] |
Motohashi Y, Yamada S, Yanagawa T, et al. (2003) Vitamin D receptor gene polymorphism affects onset pattern of type 1 diabetes. J Clin Endocrinol Metab 88: 3137-3140. doi: 10.1210/jc.2002-021881
![]() |
[23] | Mohammadnejad Z, Ghanbari M, Ganjali R, et al. (2012) Association between vitamin D receptor gene polymorphisms and type 1 diabetes mellitus in Iranian population. Mol Biol Rep 39: 831-837. |
[24] |
Zemunik T, Skrabic V, Boraska V, et al. (2005) FokI polymorphism, vitamin D receptor, and interleukin-1 receptor haplotypes are associated with type 1 diabetes in the Dalmatian population. J Mol Diagn 7: 600-604. doi: 10.1016/S1525-1578(10)60593-4
![]() |
[25] |
Abd-Allah SH, Pasha HF, Hagrass HA, et al. (2014) Vitamin D status and vitamin D receptor gene polymorphisms and susceptibility to type 1 diabetes in Egyptian children. Gene 536: 430-434. doi: 10.1016/j.gene.2013.12.032
![]() |
[26] | Chiang JL, Kirkman MS, Laffel LMB, et al. (2014) Type1 Diabetes through the Life Span: A position statement of the American Diabetes Association. Diabetes Care 20: 2034-2054. |
[27] |
Rigby WF, Stacy T, Fanger MW, et al. (1984) Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol). J Clin Investig 74: 1451-1455. doi: 10.1172/JCI111557
![]() |
[28] | Mathieu C, van Etten E, Decallonne B, et al. (2004) Vitamin D and 1,25-dihydroxyvitamin D3 as immunomodulators in the immune system. J Steroid Biochem Mol Biol 89: 449-452. |
[29] | Muller K, Bendtzen K (1992) Inhibition of human T lymphocyte proliferation and cytokine production by 1,25-dihydroxyvitamin D3. Differential effects on CD45RA+ and CD45RO+ cells. Autoimmunity 14: 37-43. |
[30] | Tattersall RB, Pyke DA (1972) Diabetes in identical twins. Lancet 2: 1120-1125. |
[31] |
Redondo MJ1, Fain PR, Eisenbarth GS (2001) Genetics of type 1A diabetes. Recent Prog Horm Res 56: 69-89. doi: 10.1210/rp.56.1.69
![]() |
[32] | Babiker HM, Schlebusch CM, Hassan HY, et al. (2011) Genetic variation and population structure of Sudanese populations as indicated by 15 Identifiler sequence-tagged repeat (STR) loci. Investig Genet 2: 12. |
[33] |
Dobon B, Hassan HY, Laayouni H, et al. (2015) The genetics of East African populations: a Nilo-Saharan component in the African genetic landscape. Sci Rep 5: 9996. doi: 10.1038/srep09996
![]() |
[34] | Obi-Tabot ET, Tian XQ, Chen TC, et al. (2000) A human skin equivalent model that mimics the photoproduction of vitamin D3 in human skin. In Vitro Cell Dev Biol Anim 36: 201-204. |
[35] | Zhang J, Li W, Liu J, et al. (2012) Polymorphisms in the vitamin D receptor gene and type 1 diabetes mellitus risk: an update by meta-analysis. Mol Cell Endocrinol 355: 135-142. |
[36] |
Wang G, Zhang Q, Xu N, et al. (2014) Associations between two polymorphisms (FokI and BsmI) of vitamin D receptor gene and type 1 diabetes mellitus in Asian population: a meta-analysis. PLoS One 9: e89325. doi: 10.1371/journal.pone.0089325
![]() |
[37] |
Morrison NA, Qi JC, Tokita A, et al. (1994) Prediction of bone density from vitamin D receptor alleles. Nature 367: 284-287. doi: 10.1038/367284a0
![]() |
[38] | Mimbacas A, Trujillo J, Gascue C, et al. (2007) Prevalence of vitamin D receptor gene polymorphism in a Uruguayan population and its relation to type 1 diabetes mellitus. Genet Mol Res 6: 534-542. |
[39] |
Cheon CK, Nam HK, Lee KH, et al. (2015) Vitamin D receptor gene polymorphisms and type 1 diabetes mellitus in a Korean population. Pediatr Int 57: 870-874. doi: 10.1111/ped.12634
![]() |
1. | Mohammed H. HASSAN, Ghaydaa A. SHEHATA, Ahmed E. AHMED, Samer A. EL-SAWY, Amal M. TOHAMY, Hala M. SAKHR, Ali H. BAKRI, Hebatallah ABDELLATI F, Hesham H. AMEEN, Ahmed A. ABDALLAH, Nagwan I. RASHWAN, Vitamin D3 status and polymorphisms of vitamin D receptor genes among cohort of Egyptian children with autism, 2023, 181, 03933660, 10.23736/S0393-3660.22.04776-3 | |
2. | Majedah A. Rasoul, Mohammad Z. Haider, Maria Al-Mahdi, Hessa Al-Kandari, Gursev S. Dhaunsi, Relationship of four vitamin D receptor gene polymorphisms with type 1 diabetes mellitus susceptibility in Kuwaiti children, 2019, 19, 1471-2431, 10.1186/s12887-019-1448-0 | |
3. | George Ciulei, Olga Hilda Orășan, Angela Cozma, Vasile Negrean, Ioana Para, Lorena Ciumărnean, Nicoleta Leach, Roxana Liana Lucaciu, Adriana Corina Hangan, Lucia Maria Procopciuc, Role of Vitamin D Receptor (BsmI-VDR) and Insulin Receptor (NsiI-A/G) Gene Polymorphisms in Colorectal Adenoma Susceptibility, 2024, 25, 1422-0067, 8965, 10.3390/ijms25168965 | |
4. | Sang Won Nam, Jinwoo Choi, Hyun Jeong Jeon, Tae Keun Oh, Dong-Hwa Lee, The Associations Between Vitamin D Receptor BsmI and ApaI Polymorphisms and Obesity in Korean Patients with Type 2 Diabetes Mellitus, 2021, Volume 14, 1178-7007, 557, 10.2147/DMSO.S293032 | |
5. | Na Zhai, Ramtin Bidares, Masoud Hassanzadeh Makoui, Saeed Aslani, Payam Mohammadi, Bahman Razi, Danyal Imani, Mohammad Yazdchi, Haleh Mikaeili, Vitamin D receptor gene polymorphisms and the risk of the type 1 diabetes: a meta-regression and updated meta-analysis, 2020, 20, 1472-6823, 10.1186/s12902-020-00575-8 | |
6. | Ali Hafedh Abbas, Ibtesam Baddai Hassan, Maysaa Kadhem Al-Malkey, Sinai Waleed Mohammed-Saeed, Genetic polymorphisms frequency of vitamin D receptor gene rs7975232 and rs731236 in Iraqi thalassemic patients and healthy controls compared to Arabian healthy populations, 2020, 25, 22145400, 100723, 10.1016/j.mgene.2020.100723 | |
7. | Hala M. Sakhr, Mohammed H. Hassan, Tarek Desoky, Possible Associations of Disturbed Neurometals and Ammonia with Glycaemic Control in Type 1 Diabetic Children with Attention Deficit Hyperactivity Disorder, 2020, 198, 0163-4984, 68, 10.1007/s12011-020-02063-5 | |
8. | Mohammed H. Hassan, Amer Alkot Mostafa Elsadek, Marwa Ahmed Mahmoud, Bakheet E. M. Elsadek, Vitamin D Receptor Gene Polymorphisms and Risk of Knee Osteoarthritis: Possible Correlations with TNF-α, Macrophage Migration Inhibitory Factor, and 25-Hydroxycholecalciferol Status, 2022, 60, 0006-2928, 611, 10.1007/s10528-021-10116-0 | |
9. | Ahmed El‐Abd Ahmed, Mohammed H. Hassan, Rana Toghan, Nagwan I. Rashwan, Analysis of 25‐hydroxy cholecalciferol, immunoglobulin E, and vitamin D receptor single nucleotide polymorphisms (Apa1, Taq1, and Bsm1), among sample of Egyptian children with bronchial asthma: A case‐control study, 2020, 55, 8755-6863, 1349, 10.1002/ppul.24785 | |
10. | Gholamreza Daryabor, Nasser Gholijani, Fatemeh Rezaei Kahmini, A review of the critical role of vitamin D axis on the immune system, 2023, 132-133, 00144800, 104866, 10.1016/j.yexmp.2023.104866 | |
11. | Eman A. Mostafa, Maha M.A. Abo Hashish, Nagwa Abdallah Ismail, Hasanin M. Hasanin, Rasha M. Hasanin, Aliaa Ahmed Wahby, Ingy Ashmawy, Shereen Hamdy Abd El Aziz, Mai Magdy Abdel Wahed, Assessment of vitamin D status and vitamin D receptor polymorphism in Egyptian children with Type 1 diabetes, 2024, 22, 1687157X, 100343, 10.1016/j.jgeb.2023.100343 | |
12. | Nur Faten Hafizah Rosli, Noor Shafina Mohd Nor, Rose Adzrianee Adnan, Siti Hamimah Sheikh Abdul Kadir, A review of vitamin D deficiency and vitamin D receptor polymorphisms in endocrine-related disorders, 2025, 68, 2713-4148, 30, 10.3345/cep.2024.00227 |
SNP | PCR primer sequences (5’-3’) | Fragment size | |
Bsm1 | Forward | CAA CCA AGA CTA CAA GTA CCG CGT CAG TGA | B: 825 bp |
Reverse | AAC CAG CGG AAG AGG TCA AGG G | b: 649 bp, 176 bp | |
Apa1 | Forward | GGG ACG CTG AGG GAT GGC AGA GC | 716 bp |
Reverse | GGA AAG GGG TTA GGT TGG ACA GGA | 481 bp, 235 bp | |
Taq1 | Forward | GGG ACG CTG AGG GAT GGC AGA GC | 716 |
Reverse | GGA AAG GGG TTA GGT TGG ACA GGA | 481 bp, 235 bp |
Characteristics | Diabetics (N = 174) | Non diabetics (N = 56) | |
Gender (years) | Male | 84 | 24 |
Female | 90 | 32 | |
Age at diagnosis (years) | 11.48 ± 3.39 | 9.50 ± 4.23 | |
Age at onset of disease | 7.68 ± 3.59 | - | |
Duration of diabetes (years) | 3.82 ± 2.82 | - | |
Family history of diabetes | Negative | 71 | 40 |
Positive | 103 | 16 | |
BMI (kg/m2) | 16.22 ± 2.37 | 19.10 ± 4.61* | |
HbA1c (%) (normal rang = 5.4–14.5) | 10.72 ± 2.18 | 6.05 ± 1.34* | |
Diabetic control | Well (≤8.0%) | 25 (14.4%) | - |
Poor (>8.0%) | 149 (85.6%) | - | |
* p < 0.001 |
Bsm1 | Genotypes | Allele | |||
Group | Bb | BB | Bb | B | B |
Diabetic patients | 17 (17%) | 51 (51%) | 32 (32%) | 0.61 | 0.58 |
Control | 21 (42%) | 19 (38%) | 10 (20%) | 0.42 | 0.39 |
P-value | = 0.004a | = 0.001 | |||
χ2 = 11.145 | χ2 = 11.014 | ||||
a statistical analysis was performed between BB + Bb and bb; Odd Ratio=0.283; 95% CI 0.131-0.609. |
Tag1 | Genotypes | Allele | |||
Group | Tt | TT | Tt | T | T |
Diabetic patients | 22 (22%) | 63 (63%) | 15 (15%) | 0.54 | 0.46 |
Control | 16 (32%) | 19 (38%) | 15 (30%) | 0.41 | 0.49 |
P-value | = 0.012a | = 0.05 | |||
χ2 = 8.877 | χ2 = 4.688 | ||||
a statistical analysis was performed between TT + Tt and tt; Odd Ratio=2.429; 95% CI 1.073-5.496. |
Apa1 | Genotypes | Allele | |||
Group | Aa | AA | Aa | A | A |
Diabetic patients | 44 (44%) | 49 (49%) | 7 (7%) | 0.68 | 0.32 |
Control | 21 (42%) | 26 (52%) | 3 (6%) | 0.68 | 0.32 |
P-value | = 0.932 a | = 0.862 | |||
χ2 = 0.141 | χ2 = 0.054 | ||||
a statistical analysis was performed between AA + Aa and aa; Odd Ratio=1.085; 95% CI 0.546-2.156. |
Genotype frequency | HbA1c (>8%) (n = 87) | HbA1c (≤8%) group (n = 13) | P value | |
Bsm1 | BB | 55 (63.2 %) | 6 (46.2 %) | 0.02a |
Bb | 9 (12.3 %) | 3 (23.0 %) | ||
Bb | 23 (26.4 %) | 4 (30.8 %) | ||
Taq1 | TT | 45 (41.4 %) | 7 (53.8%) | 0.13b |
Tt | 29 (33.3 %) | 4 (30.8 %) | ||
Tt | 13 (14.9 %) | 2 (15.4 %) | ||
Apa1 | AA | 47 (54.0 %) | 7 (53.8 %) | 0.46c |
Aa | 33 (37.9 %) | 5 (38.5 %) | ||
Aa | 7 (8.0 %) | 1 (7.7 %) | ||
a, b, c statistical analysis was performed between BB + Bb and bb; TT + Tt and tt; AA + Aa and aa. |
SNP | PCR primer sequences (5’-3’) | Fragment size | |
Bsm1 | Forward | CAA CCA AGA CTA CAA GTA CCG CGT CAG TGA | B: 825 bp |
Reverse | AAC CAG CGG AAG AGG TCA AGG G | b: 649 bp, 176 bp | |
Apa1 | Forward | GGG ACG CTG AGG GAT GGC AGA GC | 716 bp |
Reverse | GGA AAG GGG TTA GGT TGG ACA GGA | 481 bp, 235 bp | |
Taq1 | Forward | GGG ACG CTG AGG GAT GGC AGA GC | 716 |
Reverse | GGA AAG GGG TTA GGT TGG ACA GGA | 481 bp, 235 bp |
Characteristics | Diabetics (N = 174) | Non diabetics (N = 56) | |
Gender (years) | Male | 84 | 24 |
Female | 90 | 32 | |
Age at diagnosis (years) | 11.48 ± 3.39 | 9.50 ± 4.23 | |
Age at onset of disease | 7.68 ± 3.59 | - | |
Duration of diabetes (years) | 3.82 ± 2.82 | - | |
Family history of diabetes | Negative | 71 | 40 |
Positive | 103 | 16 | |
BMI (kg/m2) | 16.22 ± 2.37 | 19.10 ± 4.61* | |
HbA1c (%) (normal rang = 5.4–14.5) | 10.72 ± 2.18 | 6.05 ± 1.34* | |
Diabetic control | Well (≤8.0%) | 25 (14.4%) | - |
Poor (>8.0%) | 149 (85.6%) | - | |
* p < 0.001 |
Bsm1 | Genotypes | Allele | |||
Group | Bb | BB | Bb | B | B |
Diabetic patients | 17 (17%) | 51 (51%) | 32 (32%) | 0.61 | 0.58 |
Control | 21 (42%) | 19 (38%) | 10 (20%) | 0.42 | 0.39 |
P-value | = 0.004a | = 0.001 | |||
χ2 = 11.145 | χ2 = 11.014 | ||||
a statistical analysis was performed between BB + Bb and bb; Odd Ratio=0.283; 95% CI 0.131-0.609. |
Tag1 | Genotypes | Allele | |||
Group | Tt | TT | Tt | T | T |
Diabetic patients | 22 (22%) | 63 (63%) | 15 (15%) | 0.54 | 0.46 |
Control | 16 (32%) | 19 (38%) | 15 (30%) | 0.41 | 0.49 |
P-value | = 0.012a | = 0.05 | |||
χ2 = 8.877 | χ2 = 4.688 | ||||
a statistical analysis was performed between TT + Tt and tt; Odd Ratio=2.429; 95% CI 1.073-5.496. |
Apa1 | Genotypes | Allele | |||
Group | Aa | AA | Aa | A | A |
Diabetic patients | 44 (44%) | 49 (49%) | 7 (7%) | 0.68 | 0.32 |
Control | 21 (42%) | 26 (52%) | 3 (6%) | 0.68 | 0.32 |
P-value | = 0.932 a | = 0.862 | |||
χ2 = 0.141 | χ2 = 0.054 | ||||
a statistical analysis was performed between AA + Aa and aa; Odd Ratio=1.085; 95% CI 0.546-2.156. |
Genotype frequency | HbA1c (>8%) (n = 87) | HbA1c (≤8%) group (n = 13) | P value | |
Bsm1 | BB | 55 (63.2 %) | 6 (46.2 %) | 0.02a |
Bb | 9 (12.3 %) | 3 (23.0 %) | ||
Bb | 23 (26.4 %) | 4 (30.8 %) | ||
Taq1 | TT | 45 (41.4 %) | 7 (53.8%) | 0.13b |
Tt | 29 (33.3 %) | 4 (30.8 %) | ||
Tt | 13 (14.9 %) | 2 (15.4 %) | ||
Apa1 | AA | 47 (54.0 %) | 7 (53.8 %) | 0.46c |
Aa | 33 (37.9 %) | 5 (38.5 %) | ||
Aa | 7 (8.0 %) | 1 (7.7 %) | ||
a, b, c statistical analysis was performed between BB + Bb and bb; TT + Tt and tt; AA + Aa and aa. |